KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Share-based Compensation (2016 - 2025)

Elevance Health (ELV) has disclosed Share-based Compensation for 17 consecutive years, with $84.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Share-based Compensation rose 27.27% to $84.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $217.0 million, a 27.18% decrease, with the full-year FY2024 number at $191.0 million, changed N/A from a year prior.
  • Share-based Compensation was $84.0 million for Q3 2025 at Elevance Health, up from $81.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $92.0 million in Q2 2024 to a low of -$29.0 million in Q4 2024.
  • A 5-year average of $65.2 million and a median of $69.0 million in 2021 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: decreased 21.88% in 2022, then skyrocketed 30.65% in 2025.
  • Elevance Health's Share-based Compensation stood at $59.0 million in 2021, then rose by 23.73% to $73.0 million in 2022, then rose by 6.85% to $78.0 million in 2023, then plummeted by 137.18% to -$29.0 million in 2024, then soared by 389.66% to $84.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Share-based Compensation are $84.0 million (Q3 2025), $81.0 million (Q2 2025), and $81.0 million (Q1 2025).